| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.1B | $0.1B | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.6B | $0.5B | $0.3B | $0.3B | $0.2B | $0.1B | $0.0B | $0.0B |
| EPS (Basic) | $2.31 | $2.56 | $1.79 | $3.20 | $2.79 | $0.82 | $0.64 | $0.61 |
| EPS (Diluted) | $2.30 | $2.55 | $1.78 | $3.20 | $2.78 | $0.82 | $0.64 | $0.61 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $66.8B | $51.6B | $52.2B | $20.3B | $20.9B | $16.6B | $14.1B | $13.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $2.4B | $1.9B | $2.2B | $0.3B | $0.8B | $0.7B | $0.2B | $0.3B |
| Total Liabilities | $59.0B | $46.5B | $47.2B | $18.1B | $18.4B | $14.2B | $11.9B | $11.1B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $7.8B | $5.1B | $5.0B | $2.2B | $2.6B | $2.3B | $2.2B | $2.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.7B | $0.7B | $0.7B | $0.3B | $0.2B | $0.2B | $0.2B | $0.2B |
| Investing Cash Flow | $2.2B | $0.1B | $0.5B | $-0.4B | $-2.4B | $-1.9B | $-0.9B | $-0.5B |
| Capital Expenditures | — | — | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-2.4B | $-1.1B | $-0.3B | $-0.4B | $2.3B | $2.1B | $0.6B | $0.2B |